[HTML][HTML] COVID-19 2022 update: transition of the pandemic to the endemic phase
M Biancolella, VL Colona, R Mehrian-Shai, JL Watt… - Human genomics, 2022 - Springer
COVID-19, which is caused by the SARS-CoV-2, has ravaged the world for the past 2 years.
Here, we review the current state of research into the disease with focus on its history …
Here, we review the current state of research into the disease with focus on its history …
COVID‐19 in children. II: Pathogenesis, disease spectrum and management
AR Howard‐Jones, DP Burgner… - … of paediatrics and …, 2022 - Wiley Online Library
The global disruption of the COVID‐19 pandemic has impacted the life of every child either
directly or indirectly. This review explores the pathophysiology, immune response, clinical …
directly or indirectly. This review explores the pathophysiology, immune response, clinical …
Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data
Killer cell immunoglobulin like receptor (KIR) genes and human leukocyte antigen (HLA)
genes play important roles in innate and adaptive immunity. They are highly polymorphic …
genes play important roles in innate and adaptive immunity. They are highly polymorphic …
Association of HLA gene polymorphism with susceptibility, severity, and mortality of COVID‐19: a systematic review
P Deb, K Zannat, S Talukder, AH Bhuiyan, MSA Jilani… - Hla, 2022 - Wiley Online Library
HLA is crucial for appropriate immune responses in several viral infections, as well as in
severe acute respiratory syndrome coronavirus‐2 (SARS CoV‐2). The unpredictable nature …
severe acute respiratory syndrome coronavirus‐2 (SARS CoV‐2). The unpredictable nature …
[HTML][HTML] Concomitant septic arthritis of the hip joint and femoral head avascular necrosis in patients with recent COVID-19 infection: a cautionary report
Purpose At present, concomitant avascular necrosis (AVN) of femoral head and septic
arthritis (SA) as a sequel of COVID-19 infection has yet not been documented. By large …
arthritis (SA) as a sequel of COVID-19 infection has yet not been documented. By large …
[HTML][HTML] Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses …
SARS-CoV-2 infection results in highly heterogeneous outcomes, from cure without
symptoms to acute respiratory distress and death. Empirical evidence points to the …
symptoms to acute respiratory distress and death. Empirical evidence points to the …
[HTML][HTML] HLA alleles associated with COVID-19 susceptibility and severity in different populations: a systematic review
M Fakhkhari, H Caidi, K Sadki - Egyptian Journal of Medical Human …, 2023 - Springer
Background COVID-19 is a respiratory disease caused by a novel coronavirus called as
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Detected for the first …
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Detected for the first …
Systems-level profiling of early peripheral host-response landscape variations across COVID-19 severity states in an Indian cohort
U Banerjee, S Chunchanur, KN Balaji, A Singh… - Genes & …, 2023 - nature.com
Host immune response to COVID-19 plays a significant role in regulating disease severity.
Although big data analysis has provided significant insights into the host biology of COVID …
Although big data analysis has provided significant insights into the host biology of COVID …
[HTML][HTML] Vitamins C and D and COVID-19 susceptibility, severity and progression: an evidence based systematic review
Background and Objectives: Starting in early December 2019, the novel Coronavirus
Disease (COVID-19) from infection with COVID-19 has caused a global pandemic. Many …
Disease (COVID-19) from infection with COVID-19 has caused a global pandemic. Many …
[HTML][HTML] COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)
L Castelo-Branco, Z Tsourti, S Gennatas, J Rogado… - ESMO open, 2022 - Elsevier
Background ESMO COVID-19 and CAncer REgistry (ESMO-CoCARE) is an international
collaborative registry-based, cohort study gathering real-world data from Europe …
collaborative registry-based, cohort study gathering real-world data from Europe …